Endothelial dysfunction in acute coronary syndrome without ST segment elevation in the presence of Helicobacter pylori infection;Parametry dysfunkcji śródbłonka naczyniowego w ostrym zespole wieńcowym bez przetrwałego uniesienia odcinka ST i z zakażeniem Helicobacter pylori

Kardiologia Polska

Volumn 57, Issue 12, 2002, Pages 533-541

  Gra̧bczewska, Zofia ^a,c   Nartowicz, Edmund ^a   Szymaniak, Ludmiła ^b   Wiśniewska, Ewa ^a   Przybył, Romuald ^a   Polak, Gwidon ^a   Kubica, Jacek ^a   Dymek, Grazyna ^a   Giedrys Kalemba, Stefania ^b   Kotschy, Maria ^a   Odrowa̧z Sypniewska, Grazyna ^a   Wysocki, Henryk ^d  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b POMERANIAN MEDICAL UNIVERSITY   (Poland)

^c Medical University of Lublin Katedra i Klinika Kardiologii   (Poland)

^d IChW   (Poland)

Author keywords

Acute coronary syndrome without st elevation; Endothelium; Haemostatic factors; Helicobacter pylori

Indexed keywords

BACTERIAL ANTIGEN; CAGA PROTEIN; FIBRINOGEN; HEAT SHOCK PROTEIN; IMMUNOGLOBULIN G ANTIBODY; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN P33; PROTEIN P54; PROTEIN P57; THROMBOMODULIN; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HEART MUSCLE ISCHEMIA; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; ST SEGMENT ELEVATION; STABLE ANGINA PECTORIS; VASCULAR ENDOTHELIUM;

EID: 0036905785     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Danesh J., Collins R., Peto R.: Chronic infections and coronary heart disease: Is there a link? Lancet 1997, 350, 430-436.
2. Zatoński W., Radziszewski J.: Komentarz do artykulu (24). Medycyna po Dyplomie 1994, 3, 82-84.
3. Gasbarini A., Franceschi F., Gasbarini G. et al.: Choroby nie dotycza̧ce przewodu pokarmowego zwia̧zane z zakażeniem Helicobacter pylori. Eur. J. Gastroenterology and Hepatology (Wydanie Polskie) 1997, 9, 231-233.
4. Mendall M.A., Goggin P.M., Molineaux N. et al.: Relation of Helicobacter pylori infection and coronary heart disease. Br. Heart J. 1994, 71, 437-439.
5. Pellicano R., Broutet N., Ponzetto A. et al.: Helicobacter pylori: Od żola̧dka do serca. Eur. J. of Gastroenterology and Hepatology (Wydanie Polskie) 1999, 11, 1335-1337.
6. Skórkowska K.: Inne niż Chlamydia pneumoniae czynniki zakaźne a miażdżyca tȩtnic. Kardiol. Pol. 2001, 54, 57-61.
7. Nieminen M.S., Mattila K., Valtonen V.: Infection and inflammation as a risk factors for myocardial infarction. Eur. Heart J. 1993, 14 (suppl.), 12-16.
8. Patel P., Mendall M.A., Carrington D. et al.: Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. Br. Med. J. 1995, 311, 711-714.
9. Elizade J.I., Gomez J., Panes J. et al.: Platelet activation in mice and human Helicobacter pylori infection. J. Clin. Invest. 1997, 100, 996-1005.
10. Bierti L., Cernuschi C., Abiatic C. et al.: Correlation between gastric infection with Helicobacter pylori and plasma levels of fibrinogen, plasminogen activator inhibitor (PAI-1) and von Willebrand factor (vWF) antigen. Gut 1996, 39 (suppl.), A90.
11. Parente F., Maconi G., Imbesi V. et al.: Helicobacter pylori infection and coagulation in healthy people. Br. Med. J. 1997, 314, 1318-1319.
12. Rocnik E., Chow L.H., Pickering J.G.: Heat shock protein 47 is expressed in fibrous regions of human atheroma and is regulated by growth factors and oxidized low density lipoprotein. Circulation 2000, 101, 1229-1233.
13. Mayr M., Metzler B., Kiechl S. et al.: Endothelial cytotoxicity mediated by serum antibodies to heat shock proteins of Escherichia coli and Chlamydia pneumoniae immune reactions to heat shock proteins as a possible link between infection and atherosclerosis. Circulation 1999, 99, 1560-1566.
14. Xu Q., Kiechl S., Mayr M. et al.: Association of serum antibodies to heat shock protein 65 with carotid atherosclerosis. Circulation 1999, 100, 1169-1174.
15. Birnie D.H., Holme E.R., McKay I.C. et al.: Association between antibodies to heat shock protein 65 and coronary atherosclerosis. Eur. Heart J. 1998, 19, 387-394.
16. Murray L.J., Barnford K.B., O Reilly P.J.D. et al.: Helicobacter pylori infection: Relation with coronary heart disease and cardiovascular risk factors. Br. Heart J. 1995, 74, 497-501.
17. Pasceri V., Camrote G., Patti G. et al.: Association of virulent Helicobacter pylori strains with ischemic heart disease. Circulation 1998, 97, 1675-1679.
18. Parente F., Imbesi V., Cucino C. et al.: Helicobacter pylori CagA seropositivity does not influence inflammatory parameters, lipid concentration and hemostatic factors in healthy individuals. J. Intern. Med. 2000, 247, 213-217.
19. Juhan-Vague I., Pyke S.D.M., Alessi M.Ch. et al.: Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. Circulation 1996, 94, 2057-2063.
20. Montalescot G., Philippe F., Ankri A. et al.: Early increase of von Willebrand factor predicts adverse outcome in unstable coronary artery disease. Beneficial effects of enoxaparine. Circulation 1998, 98, 1294-1299.
21. Wodyńska T.: Czynnik von Willebranda, Trombomodulina, Tkankowy Aktywator Plazminogenu i Jego Inhibitor Typu 1 We Krwi Chorych na Niestabilna̧ i Stabilna̧ Dławicȩ Piersiowa̧. Praca doktorska, Bydgoszcz, 2001.
22. Boehme M.W., Raeth U., Scherbaum W.A. et al.: Interaction of endothelial cells and neutrophils in vitro: Kinetics of thrombomodulin, intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular adhesion molecule (VCAM-1): Implication for relevance as serological disease activity markers in vasculitides. Clin. Exp. Immunol. 2000, 119, 250-254.
23. Borcea V., Morcos M., Isermann B. et al.: Influence of ramipril on the course of plasma thrombomodulin in patients with diabetes mellitus. Vasa 1999, 28, 172-180.
24. Krespi P.D., Markis T.K., Hatzizacharias A.N. et al.: Moxonidine effect on microalbuminuria, thrombomodulin and plasminogen activator inhibitor-1 in patients with essential hypertension. Cardiovasc. Drugs Ther. 1998, 12, 463-467.
25. Ramsis N., El-Havary AA., Ismail E.: Relation between carotid intima-media thickness, platelet surface activation and endothelial cell markers. Haemostasis 1998, 28, 268-275.
26. Salomaa V., Matei C., Aleksic N. et al.: Soluble thrombomodulin as predictor of incidence coronary heart disease and symptomless carotid artery atherosclerosis in the Atherosclerosis Risk in Communities (ARIC) Study: A case-cohort study. Lancet 1999, 353, 1729-1734.